Intellect Neurosciences Inc. (fka ILNS)

[john1045]

If any or all of the current trials moving to completion in next few months and data is strong with no side effects, ILNS will be bought at a fair and reasonable figure IMO. My instinct tells me Maza will negotiate the best deal and like I said friedreich's ataxia data is strong, Shire will buy them out or Pfizer with Ponezumab. This is chump change for these companies. What is $30M,$40M,or $150M for ILNS portfolio that will generate hundreds of million if not billions in revenues.

From National Institute of Neurological Disorders and Stroke

There is currently no effective cure or treatment for Friedreich's ataxia.